Provided by Tiger Fintech (Singapore) Pte. Ltd.

MediciNova

1.27
+0.02001.60%
Post-market: 1.26-0.0100-0.79%16:10 EDT
Volume:9.10K
Turnover:11.46K
Market Cap:62.29M
PE:-5.27
High:1.27
Open:1.25
Low:1.25
Close:1.25
52wk High:2.55
52wk Low:1.13
Shares:49.05M
Float Shares:42.08M
Volume Ratio:0.45
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2408
EPS(LYR):-0.2253
ROE:-22.66%
ROA:-15.09%
PB:1.33
PE(LYR):-5.64

Loading ...

MediciNova Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Sep 22

MediciNova Completes Patient Enrollment for Phase 2b/3 ALS Trial of MN-166

Reuters
·
Sep 22

Medicinova Announces Completion of Patient Enrollment in Combat-ALS Phase 2B/3 Clinical Trial of Mn-166 (Ibudilast)

THOMSON REUTERS
·
Sep 22

Medicinova Announces Poster Presentation of Combat-ALS Clinical Trial at the 36TH International Symposium on ALS/Mnd

THOMSON REUTERS
·
Sep 16

MediciNova Announces Poster Presentation of COMBAT-ALS Clinical Trial at the 36th International Symposium on ALS/MND

GlobeNewswire
·
Sep 16

BRIEF-MediciNova Provides Shareholder Update on Key Developments

Reuters
·
Sep 08

MediciNova Achieves Target Enrollment for COMBAT-ALS Trial, Advances Development of MN-166 for ALS Treatment

Reuters
·
Sep 08

Medicinova Provides Shareholder Update on Key Developments

THOMSON REUTERS
·
Sep 08

MediciNova Inc. to Present Corporate Overview at H.C. Wainwright 27th Annual Global Investment Conference

Reuters
·
Sep 03

MediciNova Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Aug 27

MediciNova Inc. Achieves Enrollment Target in COMBAT-ALS Clinical Trial for MN-166

Reuters
·
Aug 27

Medicinova Achieves Enrollment in Combat-ALS Clinical Trial

THOMSON REUTERS
·
Aug 27

BRIEF-MediciNova Files Prospectus For Sale Of Up To 25 Million Shares By Selling Stockholder

Reuters
·
Aug 23

Medicinova Files Prospectus Relates to Offer, Sale of up to 25 Mln Shares of Common Stock by Ya Ii Pn, Ltd

THOMSON REUTERS
·
Aug 23

MediciNova Q2 EPS $(0.07) Beats $(0.10) Estimate, Sales $134.599K

Benzinga
·
Aug 15

MediciNova Inc expected to post a loss of 9 cents a share - Earnings Preview

Reuters
·
Aug 12

MediciNova Inc. Secures $30 Million Standby Equity Agreement to Boost R&D and Business Expansion Efforts

Reuters
·
Aug 01

Medicinova Announces Signing of a Standby Equity Purchase Agreement for up to $30 Million

THOMSON REUTERS
·
Aug 01

BRIEF-Medicinova Provides Enrollment Update For Ongoing Als And Hypertriglyceridemia Clinical Trials

Reuters
·
Jul 24

MediciNova Nears Completion of Enrollment for Key ALS and Hypertriglyceridemia Clinical Trials

Reuters
·
Jul 24